The Evolving Field of Treatment ModalitiesVideo Categories: 2018 AONN Midyear, Immunotherapy, and Video Library
Dr Morganna Freeman considers the future application of treatment modalities and how they might be combined for optimal results.
Dixie-Lee Esseltine, MD and George Mulligan, PhD offer insight on the impact of ixazomib on Takeda Oncology’s approach to multiple myeloma care and its approach to other cancer types.
Drs. Goeffrey Oxnard and Lauren Ritterhouse review the best practices to improve efficiencies in biomarker testing, including effective communication among the healthcare team, the pathologist, and the patient, as well as expediting processing in the pathology laboratory.